Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-10

The role of the vav proto-oncogene product in cell signalling

Objective



vav is a proto-oncogene expressed solely in hematopoietic cells. The protein has an array of structural features which suggests its participation in signal transduction. The analysis of mice deficient in vav expression (vav-- ) has shown the essential role of this proto-oncogene in T and B cell proliferation. The downstream signalling molecules associated with VAV are mostly unknown.
The main objective of this proposal is the identification and functional role of transducing molecules interacting with VAV. Toward this goal I propose to use the two-hybrid system which I master. This aproach is specially suited for detecting newly interacting proteins. The validity of them can be demonstrated by in vitro aproach (i,e. fusion protein) and by in vivo experiments (coimmunprecipitation of the newly detected protein). The two-hybrid system has an added advantage: it permits to delimitate domains of the proteins responsible for the interaction. From my initial screen of the Iymphoid cell cDNA library with SH3/SH2/SH3 domains of VAV as bait, I have worked close to a 15% of the true positives. I have shown that nuclear proteins Ku-70, and probably RNP C, associates with VAV. I propose to evaluate the functional role/s of these interactions by different aproaches and to investigate changes of these interactions in resting and activated hematopoietic cells. We expect that these findings might help in understanding the function/s of VAV. To detect newly interacting proteins with VAV, I propose to characterize the remaining positives from my initial screen.
We have evidences that an interaction of VAV and Grb2 exists by the two hybrid aproach and also in intact cells. This
prompted my interest to investigate the interachon of a naturally occuring isoform -Grb3.3- which cannot bind tyr phosphorylated proteins, but retains intact SH3 domains. This is of general interest, becouse some evidences show the involvement of Grb3.3 in apoptosis. I propose to utilize the two-hybrid system to study the proteins interacting -in vivo- with Grb3.3. The positives will be identify and I hope to characterize new proteins which may be involved in the apoptotic pathway of Grb3.3.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

RGI - Research grants (individual fellowships)

Coordinator

Institut National de la Santé et de la Recherche Médicale
EU contribution
No data
Address
27,Rue du Faubourg Saint-Jacques
75014 Paris
France

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (1)

My booklet 0 0